Dow plunges nearly 700 points in response to good economic news. We can explain.
A strong jobs report is good news for the economy. For stocks, not so much.
How to pick a stock: 5 essential steps for beginners
Found a stock to buy? Follow these five steps before making an investment.
MPs pressure London Stock Exchange over Chinese fast fashion giant’s £50bn listing
The London Stock Exchange (LSE) is under pressure to closely vet Chinese fast fashion giant Shein ahead of its planned £50bn listing, amid fears about forced labour in its supply chain.
Constellation Stock Is Having a Great—and Terrible—Friday
Constellation stock is up! No, it’s down! Wait, who’s right? Turns out, they both are.
Why Is Intellia Therapeutics Stock Trading Lower On Friday?
On Thursday, Intellia Therapeutics Inc (NASDAQ:NTLA) outlined its strategic priorities for 2025, emphasizing the acceleration of late-stage programs for NTLA-2002 and nex-z. These therapies target her
Cathie Wood sells $17 million of tumbling tech stock
The Nasdaq Composite has gained 34.1% in the past 12 months, while Ark Innovation ETF returned 19.1%.
Travelers Are Buying Into Delta's 'Premium' Push—And the Airline's Stock Is Rising
Delta Air Lines bills itself as the "premium" U.S. airline. Passengers appear to be buying in.
Why Is Cancer-Focused Mersana Therapeutics Stock Trading Lower On Friday?
On Friday, Mersana Therapeutics Inc. (NASDAQ:MRSN) released initial data from the Phase 1 dose escalation and backfill cohorts for emiltatug ledadotin. Emi-Le was generally well tolerated, with no Gra
Modelo Beer Maker Constellation Brands’ Stock Plummets on Lowered Growth Forecast
Constellation Brands shares plunged Friday, after the maker of beer, wine, and spirits cut its guidance as consumers held back spending.
What's Going On With COVID-19 Antibody Developer Invivyd Stock On Friday?
On Friday, Invivyd Inc. (NASDAQ:IVVD) announced that new in vitro neutralization data show continued neutralizing activity of Pemgarda (pemivibart) and pipeline candidate VYD2311 against dominant SARS